Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development. [PDF]
Gómez-Cebrián N +5 more
europepmc +1 more source
Phenotype, genotype and disease severity reflected by serum globotriaosylsphingosine Levels in patients with Fabry disease [PDF]
Eva Theswet
openalex +1 more source
Fabry disease in the haemodialysis population: outcome of a UK screening study (SoFAH). [PDF]
Ng KP +13 more
europepmc +1 more source
Ocular and confocal manifestations of Mainland Chinese with Fabry disease: a cross-sectional controlled study. [PDF]
Xu Y +6 more
europepmc +1 more source
How should kidney injury in Fabry disease be assessed and monitored? [PDF]
Song SH.
europepmc +1 more source
Elevated circulating cell-free mitochondrial DNA in fabry disease: insights into inflammatory activation. [PDF]
Yuan Y +10 more
europepmc +1 more source
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease. [PDF]
Lenders M +7 more
europepmc +1 more source
Case Report: Fabry disease presenting with electrocardiographic findings mimicking acute myocardial infarction: a diagnostic challenge. [PDF]
Xie JM, Li Q, Xiao ZQ, Zheng ZJ.
europepmc +1 more source
Cellular Lyso-Gb3 Is a Biomarker for Mucolipidosis II. [PDF]
Terawaki S +4 more
europepmc +1 more source
Proton Density of the Dorsal Root Ganglia in Classical Fabry Disease: MRI Correlates of Small Fibre Neuropathy. [PDF]
Weiner S +11 more
europepmc +1 more source

